Brain Disease Modalities And Software Market
完整報告名稱與涵蓋範圍
Brain Disease Modalities And Software Market Size, Share & Trends Analysis Report By Product (Brain Imaging Modalities and Brain Analysis Software), By Type of Patients (Adults, Pediatrics and Infants), By End-User, Region And Segment Forecasts, 2025-2034.
報告摘要
Industry analysis indicates the Brain Disease Modalities And Software Market globally will accelerate at a 5.4% CAGR during 2025–2034.
Brain Disease Modalities And Software covers medical imaging techniques that are used to diagnose and monitor brain diseases. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Market momentum is driven by rising appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Brain disease modalities and software Market Snapshot
Chapter 4. Global Brain disease modalities and software Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Products Estimates & Trend Analysis
5.1. By Products & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Products:
5.2.1. Brain analysis software
5.2.1.1. PET Devices
5.2.1.2. CT Devices
5.2.1.3. MRI Devices
5.2.1.4. PET-CT
5.2.1.5. PET-MRI
5.2.2. Brain imaging modalities
Chapter 6. Market Segmentation 2: By Type of Patients Estimates & Trend Analysis
6.1. By Products & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type of Patients:
6.2.1. Adults
6.2.2. Pediatrics
6.2.3. Infants
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. By Products & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
7.2.1. Hospitals and clinics
7.2.2. Ambulatory surgery centers
7.2.3. Diagnostic imaging centers
Chapter 8. Brain disease modalities and software Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034
8.1.2. North America Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By Type of Patients, 2021-2034
8.1.3. North America Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
8.1.4. North America Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Brain disease modalities and software Market revenue (US$ Million) By Products, 2021-2034
8.2.2. Europe Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By Type of Patients, 2021-2034
8.2.3. Europe Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By End User 2021-2034
8.2.4. Europe Brain disease modalities and software Market revenue (US$ Million) by country, 2021-2034
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Brain disease modalities and software Market revenue (US$ Million) By Products, 2021-2034
8.3.2. Asia Pacific Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By Type of Patients, 2021-2034
8.3.3. Asia Pacific Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
8.3.4. Asia Pacific Brain disease modalities and software Market revenue (US$ Million) by country, 2021-2034
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Brain disease modalities and software Market revenue (US$ Million) By Products, 2021-2034
8.4.2. Latin America Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By Type of Patients, 2021-2034
8.4.3. Latin America Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
8.4.4. Latin America Brain disease modalities and software Market revenue (US$ Million) by country, (US$ Million) 2021-2034
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. Middle East & Africa
8.5.1. Middle East & Africa Brain disease modalities and software Market revenue (US$ Million) By Products, (US$ Million)
8.5.2. Middle East & Africa Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By Type of Patients, 2021-2034
8.5.3. Middle East & Africa Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
8.5.4. Middle East & Africa Brain disease modalities and software Market revenue (US$ Million) by country, (US$ Million) 2021-2034South Africa
8.5.4.1. GCC Countries
8.5.4.2. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Quantib
9.2.2. Brainomix
9.2.3. Qure.AI
9.2.4. General Electric Company
9.2.5. Imaging Biometrics, LLC
9.2.6. United Imaging Healthcare Co. Ltd.
9.2.7. Siemens
9.2.8. Healthineers AG
9.2.9. Koninklijke Philips N.V.
9.2.10. Canon Inc.
9.2.11. Vuno Co. Ltd.
9.2.12. Aspect Imaging
9.2.13. IXICO
9.2.14. QMENTA
9.2.15. Cortechs.ai
9.2.16. A.I. Analysis Inc.
9.2.17. Fujifilm Holdings Corporation
9.2.18. Other Prominent Players.
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們